- 专利标题: POLYPEPTIDE, FUSED POLYMER PROTEIN AND USE THEREOF
-
申请号: EP22940501.4申请日: 2022-12-21
-
公开(公告)号: EP4353739A1公开(公告)日: 2024-04-17
- 发明人: LI, Yanjun , LI, Gang , GU, Tongnian , ZHANG, Jiantao , LIU, Long , LEI, Xiaoju , LIU, Qiong
- 申请人: Sunresin New Materials Co., Ltd.
- 申请人地址: CN Xi'an, Shaanxi 710075 No. 135, Jinye Rd Xi'an Hi-tech Industrial Dvelopment Zone
- 专利权人: Sunresin New Materials Co., Ltd.
- 当前专利权人: Sunresin New Materials Co., Ltd.
- 当前专利权人地址: CN Xi'an, Shaanxi 710075 No. 135, Jinye Rd Xi'an Hi-tech Industrial Dvelopment Zone
- 代理机构: J A Kemp LLP
- 优先权: CN 202211064221 2022.09.01
- 国际申请: CN2022140536 2022.12.21
- 国际公布: WO2024045430 2024.03.07
- 主分类号: C07K14/31
- IPC分类号: C07K14/31 ; C07K19/00 ; C07K16/00 ; C07K1/22 ; C12N15/31 ; C12N15/62 ; C12N15/70 ; C12N1/21 ; G01N33/68 ; B01D15/38 ; C12R1/19
摘要:
The present invention relates to the technical field of protein biological functions, in particular to a polypeptide, a fusion type multimeric protein and use thereof, the polypeptide is selected from: (1), a polypeptide having a substitution mutation in at least one position selected from the group consisting of positions 16, 25, 29, 49 and 58, as compared with a natural C structural domain of a protein A as shown in SEQ ID NO.1; wherein, the position 16 is subjected to a substitution mutation into leucine or valine; the position 25 is subjected to a substitution mutation into lysine, arginine, histidine or tryptophan; the position 29 is subjected to a substitution mutation into alanine, leucine or threonine; the position 49 is subjected to a substitution mutation into arginine or histidine; and the position 58 is subjected to a substitution mutation into glycine, isoleucine or alanine; or (2) a polypeptide having at least 80% of sequence identity to the polypeptide in (1) and retaining substitution mutation in at least one position selected from the group consisting of positions 16, 25, 29, 49 and 58; the polypeptide has high alkali tolerance and high loading capacity.
信息查询